- Motley Fool•8 days ago
Endo International, Horizon Pharma, and Valeant Pharmaceuticals have all run into a proverbial buzz saw this year. But these beaten-down specialty pharma stocks may now be too cheap too ignore.
- Market Realist•18 days ago
Horizon operates through three segments: Primary Care, Orphan Drugs, and Rheumatology. It proposes to become an orphan disease drug company by fiscal 2020.
Horizon Pharma plcNasdaqGS
After hours: 19.29-0.00 (-0.02%) as of 4:46 PM EDT
|Bid||18.75 x 200|
|Ask||19.47 x 1000|
|52wk Range||12.86 - 37.00|
|Day's Range||19.24 - 19.85|
|Avg Vol (3m)||3,951,020|
As of 4:00 PM EDT. Market closed.